Target intelligence / Profile preview

Nucleoporin 210 pseudogene 2 (NUP210P2)

Target
NUP210P2
Molecular classification
Pseudogene
01

Overview

Nucleoporin 210 pseudogene 2 (NUP210P2) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a functional gene (in this case, NUP210) but does not encode an active protein. Pseudogenes typically arise from duplication or retrotransposition events and accumulate mutations that prevent them from producing a functional product. As such, NUP210P2 does not serve as a therapeutic or druggable molecular target and has no known biological functions, disease associations, or clinical relevance[5]. Functional NUP210 (Nucleoporin 210, also called gp210) is a well-characterized component of the nuclear pore complex, with roles in nuclear envelope assembly and some autoimmune and cancer relevance[2][3][1]. However, NUP210P2 is distinct and non-functional. No aliases or biological functions are listed in the major gene databases for NUP210P2[5]. The apparent confusion can arise because pseudogenes are often named similarly to their functional counterparts, but should not be considered targets for pharmacological or biological intervention.

Beyond the preview

Go deeper on Nucleoporin 210 pseudogene 2 (NUP210P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleoporin 210 pseudogene 2 (NUP210P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call